Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Newsletter Articles
|
QA panel answers numerous puzzlers. (National Petroleum Refiners Association QA Session)Moore, John AThe Oil Daily, 1987, p.SAEnergy Intelligence GroupTexto completo disponível |
|
2 |
Material Type: Newsletter Articles
|
Cocaine-binding scFv antibody can be made in E. coli, purified, freeze-driedHealth & Medicine Week, 2004, p.527NewsRX LLCTexto completo disponível |
|
3 |
Material Type: Newsletter Articles
|
Immunoglobulins; Cocaine-binding scFv antibody can be made in E. coli, purified, freeze-driedProteomics Weekly, 2004, p.100Atlanta: NewsRxTexto completo disponível |
|
4 |
Material Type: Newsletter Articles
|
Cocaine-binding scFv antibody can be made in E. coli, purified, freeze-driedBiotech Week, 2004, p.526NewsRX LLCTexto completo disponível |
|
5 |
Material Type: Newsletter Articles
|
Scripps Research Institute; Cocaine-binding scFv antibody can be made in E. coli, purified, freeze-driedBiotech Week, 2004, p.422Atlanta: NewsRxTexto completo disponível |
|
6 |
Material Type: Newsletter Articles
|
Immunoglobulins; Cocaine-binding scFv antibody can be made in E. coli, purified, freeze-dried: 1Drug Week, 2004, p.328Atlanta: NewsRxTexto completo disponível |
|
7 |
Material Type: Newsletter Articles
|
Vulvar Cancer; Specific factors identified to add to vulvar cancer- specific QOL subscaleClinical Oncology Week, 2004, p.107Atlanta: NewsRxTexto completo disponível |
|
8 |
Material Type: Newsletter Articles
|
Vulvar Cancer; Specific factors identified to add to vulvar cancer- specific QOL subscaleOBGYN & Reproduction Week, 2004, p.94Atlanta: NewsRxTexto completo disponível |
|
9 |
Material Type: Newsletter Articles
|
Specific factors identified to add to vulvar cancer-specific QOL subscaleOBGYN & Reproduction Week, 2004, p.94NewsRX LLCTexto completo disponível |
|
10 |
Material Type: Newsletter Articles
|
Specific factors identified to add to vulvar cancer-specific QOL subscaleClinical Oncology Week, 2004, p.107NewsRX LLCTexto completo disponível |